| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |